mesalamine and Cholecystoduodenal Fistula
mesalamine has been researched along with Cholecystoduodenal Fistula in 10 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"Diarrhea is a common clinical feature of inflammatory bowel diseases and may be accompanied by abdominal pain, urgency, and fecal incontinence." | 2.48 | Diarrhea in chronic inflammatory bowel diseases. ( Wenzl, HH, 2012) |
"The aetiology of Crohn's disease still remains obscure, therefore medical therapy is directed towards symptomatic relief in active disease and relapse prevention in the long-term setting." | 2.42 | Review article: medical treatment of mild to moderately active Crohn's disease. ( Löfberg, R, 2003) |
"Separate risk prediction models for Crohn's disease-related surgery and complications were developed using clinical trial data involving community gastroenterology practices." | 1.48 | Development of Clinical Prediction Models for Surgery and Complications in Crohn's Disease. ( Dulai, PS; Feagan, BG; Guizzetti, L; Jairath, V; Khanna, R; Sandborn, WJ; Zou, G, 2018) |
"The incidence of Crohn's disease has steadily increased over the past several decades." | 1.48 | ACG Clinical Guideline: Management of Crohn's Disease in Adults. ( Gerson, LB; Isaacs, KL; Lichtenstein, GR; Loftus, EV; Regueiro, MD; Sands, BE, 2018) |
"Prednisone dosage was reduced from a mean of 19." | 1.32 | Immunomodulators and "on demand" therapy with infliximab in Crohn's disease: clinical experience with 400 infusions. ( France, R; Kinney, T; Kozarek, R; Patterson, D; Rawlins, M, 2003) |
"Gastroduodenal Crohn disease is a complex and difficult problem that is associated with serious complications and need for reoperation." | 1.30 | An audit of gastroduodenal Crohn disease: clinicopathologic features and management. ( Allan, RN; Keighley, MR; Yamamoto, T, 1999) |
Research
Studies (10)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 5 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Guizzetti, L | 1 |
Zou, G | 1 |
Khanna, R | 1 |
Dulai, PS | 1 |
Sandborn, WJ | 1 |
Jairath, V | 1 |
Feagan, BG | 1 |
Lichtenstein, GR | 1 |
Loftus, EV | 1 |
Isaacs, KL | 1 |
Regueiro, MD | 1 |
Gerson, LB | 1 |
Sands, BE | 1 |
Gargallo Puyuelo, CJ | 1 |
Sopeña, F | 1 |
Lanas Arbeloa, A | 1 |
Hall, J | 1 |
Hammerich, K | 1 |
Roberts, P | 1 |
Wenzl, HH | 1 |
Kinney, T | 1 |
Rawlins, M | 1 |
Kozarek, R | 1 |
France, R | 1 |
Patterson, D | 1 |
Löfberg, R | 1 |
Caprilli, R | 1 |
Gassull, MA | 1 |
Escher, JC | 1 |
Moser, G | 1 |
Munkholm, P | 1 |
Forbes, A | 1 |
Hommes, DW | 1 |
Lochs, H | 1 |
Angelucci, E | 1 |
Cocco, A | 1 |
Vucelic, B | 1 |
Hildebrand, H | 1 |
Kolacek, S | 1 |
Riis, L | 1 |
Lukas, M | 1 |
de Franchis, R | 1 |
Hamilton, M | 1 |
Jantschek, G | 1 |
Michetti, P | 1 |
O'Morain, C | 1 |
Anwar, MM | 1 |
Freitas, JL | 1 |
Mouzas, IA | 1 |
Baert, F | 1 |
Mitchell, R | 1 |
Hawkey, CJ | 1 |
Treepongkaruna, S | 1 |
Pienvichit, P | 1 |
Sornmayura, P | 1 |
Pornkul, R | 1 |
Wisedopas, N | 1 |
Phuapradit, P | 1 |
Yamamoto, T | 1 |
Allan, RN | 1 |
Keighley, MR | 1 |
Clinical Trials (4)
Trial Overview
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Multicentre Controlled, Randomized Clinical Trial to Compare the Efficacy and Safety of Ambulatory Treatment of Mild Acute Diverticulitis Without Antibiotics With the Standard Treatment With Antibiotics[NCT02785549] | Phase 4 | 480 participants (Actual) | Interventional | 2016-11-30 | Completed | ||
Synbiotic Treatment in Crohn's Disease Patients[NCT00305409] | 50 participants (Anticipated) | Interventional | 2006-06-30 | Completed | |||
MeSenteric SpAring Versus High Ligation Ileocolic Resection for the Prevention of REcurrent Crohn's DiseaSe (SPARES)[NCT04578392] | 181 participants (Anticipated) | Interventional | 2020-07-28 | Recruiting | |||
A Randomized, Controlled, Open-label Study to Assess the Efficacy of T2 Versus Azathioprine for the Maintenance of Clinical and Endoscopic Remission in Subjects With Crohn's Disease After Surgical Resection[NCT01015391] | 100 participants (Anticipated) | Interventional | 2009-11-30 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Reviews
4 reviews available for mesalamine and Cholecystoduodenal Fistula
Article | Year |
---|---|
Colonic diverticular disease. Treatment and prevention.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Combined Modality Therapy; Contraind | 2015 |
New paradigms in the management of diverticular disease.
Topics: Age Factors; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Colectomy; Diagnosis, D | 2010 |
Diarrhea in chronic inflammatory bowel diseases.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidiarrheals; Bacterial Infections | 2012 |
Review article: medical treatment of mild to moderately active Crohn's disease.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Monoclonal; Colonic Diseases; Crohn Diseas | 2003 |
Other Studies
6 other studies available for mesalamine and Cholecystoduodenal Fistula
Article | Year |
---|---|
Development of Clinical Prediction Models for Surgery and Complications in Crohn's Disease.
Topics: Abdominal Abscess; Adrenal Cortex Hormones; Adult; Age Factors; Anti-Inflammatory Agents, Non-Steroi | 2018 |
ACG Clinical Guideline: Management of Crohn's Disease in Adults.
Topics: Adalimumab; Adrenal Cortex Hormones; Antibodies, Monoclonal; Certolizumab Pegol; Crohn Disease; Dise | 2018 |
Immunomodulators and "on demand" therapy with infliximab in Crohn's disease: clinical experience with 400 infusions.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Crohn Disease; Drug Therapy, | 2003 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |
Inflammatory bowel disease in Thai children: presentations and outcomes of treatment.
Topics: Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Child; C | 2006 |
An audit of gastroduodenal Crohn disease: clinicopathologic features and management.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Child; Constriction, Pathologic; C | 1999 |